TMO Market Analysis
Wall Street coverage
third-party contextWall Street coverage
Via 3rd party. Not a recommendation or advice by The Balanced Investor Club. See disclaimer.
News & Sentiment
25 articles · sorted by dateVia 3rd party. Not a recommendation or advice by The Balanced Investor Club. See disclaimer.
Fundamentals
Updated daily after market closeValuation
- Forward P/E
- 24.15
- PEG ratio
- 1.98
- P/B
- 4.67
- P/S (TTM)
- 5.51
- EV/EBITDA
- 23.62
Profitability & growth
- ROE (TTM)
- 13.5%
- Operating margin
- 18.8%
- Revenue growth YoY
- 10.5%
- Dividend yield
- 0.3%
- Beta
- 0.88
Ratios are point-in-time. Historical metrics — no guarantees about what comes next.
About Thermo Fisher Scientific Inc
Company profileThermo Fisher Scientific is an American provisioner of scientific instrumentation, reagents and consumables, and software and services to healthcare, life science, and other laboratories in academia, government, and industry (including in the biotechnology and pharmaceutical sectors). Based in Waltham, Massachusetts, Thermo Fisher was created in 2006 by the merger of Thermo Electron and Fisher Scientific, to form a company with US$ 9 billion in combined revenues.
Classification
- Sector
- Healthcare
- Industry
- Diagnostics & Research
- Exchange
- NYSE
- Country
- USA
- Currency
- USD
Company profile
- HQ
- 168 THIRD AVENUE, WALTHAM, MA
- Fiscal year end
- December
- Latest quarter
- Jun 30, 2026
We're educators, not advisors. We don't make buy or sell recommendations under any circumstance. All content is for educational purposes. Past performance doesn't guarantee future results. Your decisions are your own. Disclaimer
